Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

1,5-(Butylimino)-1,5-dideoxy, D-glucitol

EU orphan designation number: EU/3/00/006
Active ingredient: 1,5-(Butylimino)-1,5-dideoxy, D-glucitol
Indication: Treatment of Gaucher Disease
Sponsor: Actelion Registration Ltd
90 Fetter Lane, London EC4A 7JP, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Zavesca on 20/11/2002 with the number EU/1/02/238

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/11/2000 Orphan designation EMEA/OD/023/00 (2000)328 of 18/10/2000
08/03/2003 Transfer of orphan designation EMEA/OD/023/00/T/01 (2003)693 of 07/03/2003
21/11/2012 Removal of orphan designation from Community Register